Discover the complete record of transactions filed by Michel Picot, Director. Officer active across 1 companies, notably EUROBIO-SCIENTIFIC. Cumulatively, 1 disclosures have been published. Total volume traded: €87k. The latest transaction was filed on 5 December 2024 — Apport à une offre publique d'acquisition. Regulator: AMF. All data is free.
1 of 1 declaration
Michel Picot is a seasoned French business executive and a current director of EUROBIO-SCIENTIFIC, where he represents EUROBIONEXT, the company’s reference shareholder. His career spans finance, corporate leadership, and governance roles in listed and technology-driven companies. According to Eurobio Scientific’s corporate communications, he began his career as an auditor at Peat Marwick Mitchell before moving to SCOA, a Parisbas affiliate, and later to ECS Germany. He then took on senior financial responsibilities at Eunetcom as Senior Vice President Finance. His profile broadened further when he became Deputy Chief Executive Officer of Vivendi Telecom International, a position he held for nearly ten years. Since 2005, he has served as Chairman of Advest SAS. He has also chaired the Supervisory Board of Elektrion Telekomunikaeja since 2001 and has been a director of Keyyo since 2005. An HEC graduate with additional qualifications in accounting and control (DECS), Michel Picot has developed strong expertise in corporate finance, strategic oversight, and the management of complex organizations. His background reflects a combination of hands-on operational leadership, board-level governance, and deep familiarity with listed-company environments and the telecom and technology sectors. At EUROBIO-SCIENTIFIC, he plays a role in board supervision and strategic guidance for a French specialist diagnostics group with a growing international footprint. His career profile is that of a governance-focused executive with a strong financial track record and extensive experience in value creation, corporate structuring, and long-term stewardship.